Ocular Therapeutix Inc (OCUL)

Cost of Revenue

$6.71M

TTM · Period ending: · USD

OCUL logo

OCUL Cost of Revenue

Latest reported$6.71M
OCUL TTM Cost of Revenue ($10.52M → $6.71M)
High-resolution chart · PNG

OCUL cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ocular Therapeutix Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,708,000
6,641,000
6,574,000
6,210,000
5,997,000
5,562,000
5,626,000
5,782,000
5,598,000
5,393,000
5,281,000
4,907,000
4,603,000
4,454,000
4,540,000
4,636,000
4,873,000
4,814,000
4,406,000
3,978,000
3,118,000
2,156,000
2,083,000
2,242,000
2,598,000
3,016,000
2,325,000
1,603,000
912,000
513,000
465,000
461,000
471,000
422,000
457,000
471,000
458,000
459,000
443,000
408,000
387,000
362,000
319,000
257,000
198,000
138,000
91,000
10,578,000
10,546,000
10,526,000
10,517,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.